Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Global Antimicrobial Resistance|February 17, 2021
Clinical efficacy and safety of cefiderocol in the treatment of acute bacterial infections: A systematic review and meta-analysis of randomised controlled trialsShun-Chung Hsueh, Chien-Ming Chao, Cheng-Yi Wang, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2018
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in TaiwanShun-Chung Hsueh, Yuarn-Jang Lee, Yu-Tsung Huang, et al.
International Journal of Antimicrobial Agents|March 23, 2020
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic statusChih-Cheng Lai, Cheng-Yi Wang, Ya-Hui Wang, et al.
Journal of Global Antimicrobial Resistance|February 8, 2024
In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014-2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatmentShun-Chung Hsueh, Yu-Tsung Huang, Wen-Chien Ko, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 15, 2024
Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in TaiwanLi-Kuo Kuo, Hou-Tai Chang, Shun-Chung Hsueh, et al.
Journal of Medical Virology|December 26, 2022
Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomesChih-Cheng Lai, Chi-Kuei Hsu, Shun-Chung Hsueh, et al.
Journal of Global Antimicrobial Resistance|July 2, 2026
Aztreonam-Avibactam and Cefiderocol against Metallo-β-Lactamase-Producing Enterobacterales and Other Carbapenem-Resistant Gram-Negative Pathogens: Microbiological Activity and Clinical EvidenceChih-Cheng Lai, Chia-Ying Liu, Shun-Chung Hsueh, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2026
Cefiderocol nonsusceptibility among carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) programPo-Wei Chiu, Jiun-Ling Wang, Shun-Chung Hsueh, et al.
Frontiers in Microbiology|September 25, 2020
Molecular Evidence for Intra- and Inter-Farm Spread of Porcine mcr-1-Carrying Escherichia coli in TaiwanShun-Chung Hsueh, Chih-Cheng Lai, Yu-Tsung Huang, et al.
International Journal of Antimicrobial Agents|November 19, 2025
Ceftazidime-avibactam resistance among clinical isolates of Citrobacter freundii, Morganella morganii, Providencia spp. and Serratia marcescens across five continents: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016-2023Hao-En Jan, Jiun-Ling Wang, Nan-Yao Lee, et al.
Pageof 2